It is increasingly recognized that metabolic tissue can activate the insulin growth factor signaling pathway [33] and proinflammatory mediators, including macrophages, T cells and tumor necrosis factor-alpha [34], [35], which, in turn, create a favorable microenvironment for tumor development and progression. The gene discussed is TNF; the disease is neoplasm.